Mirror Biologics
Blood & Organ Banks · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3500 E Fletcher Ave Ste 425, Tampa, Flor...Website
www.mirrorbio.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
4
2
2
3
2
2
About Mirror Biologics
Founded in 2018 and headquartered in Tampa, Florida, Mirror Biologics is a clinical-stage, international biopharmaceutical company pioneering the development and manufacturing of the next generation of immunomodulatory vaccines and immunotherapy treatments where the active ingredients include living immune cells.Explore more
Mirror Biologics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mirror Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Mirror Biologics recently announced quarterly report
Product Launch: Get notified when Mirror Biologics launches new products
Congratulate Masked Content for being promoted to Masked Content at Mirror Biologics
Check if Mirror Biologics has recently received funding, and reach out quickly before it becomes old news!
Mirror Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Mirror Biologics has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Mirror Biologics had a recent Job posting/layoffs
Check out if Mirror Biologics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Mirror Biologics as Masked Content
Find more new buyers
Compare Similar Companies to Mirror Biologics
Compare insights from companies similar to Mirror Biologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Mirror Biologics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Mirror Biologics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Mirror Biologics.
Mirror Biologics financials insights
Gather financial insights about Mirror Biologics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Private Equity
$14M
2022
Series A
$30M
Mirror Biologics Tech Stack
A closer look at the technologies used by Mirror Biologics
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
New Hire
Executive Move
Executive Moves
Lateral Move
Executive Move
Executive Moves
Lateral Move
Executive Move
Executive Moves
Mirror Biologics News & Media
Mirror Biologics Enters Clinical Collaboration with Merck KGaA, Darmstadt, Germany in Metastatic Colorectal Cancer
TAMPA, Fla., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Mirror Biologics, Inc., specializing in development and manufacturing of immunotherapy products where the active ingredient is living, non-genetically altered, allogeneic (“off-the-shelf”) immune cells, announces that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany. The parties will collaborate to conduct a Phase II clinical trial to evaluate the combination of an experimental immunotherapyMirror Biologics, Inc. Appoints Elizabeth Czerepak as Chief Financial Officer and VP Corporate Development
Mirror Biologics, Inc., a clinical stage biopharmaceutical company announces the appointment of Elizabeth Adkins Czerepak as Chief Financial Officer (CFO) and Vice President of Corporate Development effective April 15, 2024. Ms. Czerepak has served as CFO of several biotechnology companies over the last 13 years. She has also led teams that successfully launched public offerings over this time. In addition, she has 10 [PR.com]Mirror Biologics, Inc. Announces Appointment of Brian Cregger as Vice President of Engineering Research and Development
Mirror Biologics, Inc., a clinical stage biopharmaceutical company, today announced that Brian Cregger was appointed as Vice President of Engineering Research and Development effective January 3, 2023. Mr. Cregger assumes the critical role of leading the development of Mirror’s artificial lymph node bioreactor systems and automated manufacturing pods for commercial production and distribution of living cell [PR.com]Mirror Biologics, Inc. Announces Appointment of Yi Chen as Executive Vice President of Corporate Strategy and Planning
Mirror Biologics, Inc., a clinical stage biopharmaceutical company, today announced that Yi Shen, MBA was appointed as as Executive Vice President of Corporate Strategy and Planning on November 15, 2022. Ms. Shen assumed the critical role of mapping out the strategic and operational pathways of the Company’s product candidates to successful commercialization. Ms. Shen has 19 years of industry and consulting [PR.com]
Read more news
Top Blood & Organ Banks Companies
See more top companies
Frequently Asked Questions Regarding Mirror Biologics
Sign Up For FreeTo access detailed company insights
Founded in 2018 and headquartered in Tampa, Florida, Mirror Biologics is a clinical-stage, international biopharmaceutical company pioneering the development and manufacturing of the next generation of immunomodulatory vaccines and immunotherapy treatments where the active ingredients include living immune cells.... Read More
